Carlton South Vic 3053, Australia
Go to Investors Hub
info@radiopharmtheranostics.com
Latest News

Radiopharm Theranostics
Category: Announcements

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
Radiopharm Receives $4.5M R&D Tax Incentive
Quarterly Activities & Cash Report
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for 161Tb-KLK3-mAb Phase I Clinical Trial in Australia
Notice Under Section 708A
Application for quotation of securities – RAD
RAD Granted US FDA Fast Track for RAD101 Metastases Imaging
Proposed issue of securities – RAD
Categories
Announcements
Announcements
Annual Reports
Annual Reports
Presentations
Presentations
News
News
Recent News
Analyst ReportsAnnouncementsAnnual ReportsInvestor PresentationsRAD ArticlesUpdates
Tags
Tags
Appendix 2A (1) Appendix 3B (1) Change of Director's Interest Notice (1) Cleansing Notice (1) PDF (34) Periodic Reports (25) Price Sensitive (84) Progress Report (2) Video (3) With Summary (2) With Video (4)
Archives
Archives
RSS RSS
Close
Search

Hit enter to search or ESC to close

cookie By using this website, you agree to our cookie policy. Close